spacer
The Healthcare Sales & Marketing Network celebrates 22 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: Biopharmaceuticals

 HSMN NewsFeed - 28 May 2020
Cardiff Oncology Announces Fast Track Designation Granted by the FDA to Onvansertib for Second-Line Treatment of KRAS-Mutated Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 May 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 May 2020
Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2020
Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 May 2020
Emgality(R) Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a History of Preventive Treatment Failure
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 May 2020
Medivir Appoints Yilmaz Mahshid as New CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 May 2020
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 22 May 2020
Hikma receives FDA approval for its generic Vascepa(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 May 2020
Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 May 2020
HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 May 2020
Cipla Receives Final Approval for Generic Version of Migranal(R) (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) With a Competitive Generic Therapy Designation
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 20 May 2020
Dr Tara Heitner Appointed New CEO for Cyxone
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2020
AllianceRx Walgreens Prime One of Only Two Specialty Pharmacies to Distribute Vyepti(TM), the First and Only Intravenous Preventive Treatment for Migraine
Biopharmaceuticals Distribution
 HSMN NewsFeed - 19 May 2020
BioEclipse Therapeutics(TM) Announces Move to New Corporate Headquarters in Mountain View, CA
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 May 2020
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 18 May 2020
Akcea Announces Appointment of New Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2020
Blueprint Medicines Receives Complete Response Letter from FDA for Avapritinib New Drug Application for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2020
U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa(R) for Third Year
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 13 May 2020
Arbor Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application (NDA) for AR19, an Investigational ADHD Prescription Stimulant Treatment Specifically Designed to Resist Physical Manipulation for Nonmedical Misuse or Abuse
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 May 2020
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2020
Vanda Pharmaceuticals Announces Agreement with FDA on Resubmission of the Application for HETLIOZ(R) for the Treatment of Patients with Smith-Magenis Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2020
Travecta Therapeutics Secures $15 Million in Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 12 May 2020
Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 11 May 2020
Jazz Pharmaceuticals Announces Appointment Of Kim Sablich As Executive Vice President, General Manager Of North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2020
Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 11 May 2020
Orexo Acquires Exclusive US Rights to Commercialize deprexis(R), A World-leading Digital Therapy to Help Patients Manage the Symptoms of Depression
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 May 2020
BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 8 May 2020
FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 7 May 2020
FogPharma Appoints Tony Gibney as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2020
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 May 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 5 May 2020
Ichnos Sciences Appoints David Lubner To Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 5 May 2020
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2020
Acesion Pharma Strengthens Clinical Team With Key Appointments
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 4 May 2020
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2020
FDA Approves FENSOLVI(R) (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2020
Alpha Cognition, Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer's Therapy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Apr 2020
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Apr 2020
AcelRx Announces DSUVIA(R) Milestone C Approval and Provides Business Update
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 30 Apr 2020
Medivir Receives Positive Opinion on Orphan Medicinal Drug Designation by the European Medicines Agency for MIV-818
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Apr 2020
ANI Receives Refusal to File Letter from FDA for Cortrophin(R) Gel
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Apr 2020
Blueprint Medicines Announces Top-line Results from Phase 3 VOYAGER Trial of Avapritinib versus Regorafenib in Patients with Advanced Gastrointestinal Stromal Tumor
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Apr 2020
Actym Therapeutics Raises $34 Million Series A
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 27 Apr 2020
JCR Pharmaceuticals announces Completion of Acquisition of ArmaGen, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Apr 2020
CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Apr 2020
Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 23 Apr 2020
SwanBio Therapeutics Announces Series A Expansion to Fund its Lead Program and Grow Pipeline in Gene Therapy for Neurological Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 22 Apr 2020
FoRx Therapeutics AG Raises EUR 10 Million Seed Round and Becomes First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 22 Apr 2020
Novartis Kymriah(R) receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
Biopharmaceuticals Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 21 Apr 2020
IDEAYA Biosciences Announces Addition of Julie Patel as Vice President, Human Resources, Enhancing its Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2020
Moleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus Testing
Biopharmaceuticals
 HSMN NewsFeed - 20 Apr 2020
Amblyotech, A Digital Therapeutics Company, Announces It Has Been Acquired by Novartis
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 20 Apr 2020
MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 17 Apr 2020
PTC Therapeutics Announces New Leadership Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2020
Hoth Therapeutics Announces Additions to its Board of Directors
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 16 Apr 2020
Provention Bio Initiates Rolling Submission of Biologic License Application for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-Risk Individuals
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Apr 2020
Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Apr 2020
ANI Announces Upcoming Departure of CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2020
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin(R) Gel 80 U/mL
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Apr 2020
Stealth Biotherapeutics Announces $20 Million Financing to Advance Development of Elamipretide and Pipeline
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2020
BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2020
Bolt Biotherapeutics Appoints Edith Perez, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Apr 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Apr 2020
Viracta Receives Welcome FDA Guidance at Type C Meeting for the Treatment of EBV-Associated Lymphomas
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Apr 2020
Third Pole Therapeutics Announces Global Commercialization Agreement with Chiesi Group for Its Tankless, Portable Inhaled Nitric Oxide (iNO) Delivery System
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Apr 2020
Portola Pharmaceuticals Announces the Establishment of a Permanent J-code for Andexxa by the Centers for Medicare & Medicaid Services, Effective July 1, 2020
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 6 Apr 2020
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren(R) Arthritis Pain
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Apr 2020
HEMA Biologics(TM) Announces FDA Approval of SEVENFACT(R) [coagulation factor VIIa (recombinant)-jncw] for Treatment and Control of Bleeding Episodes Occurring in Adult and Adolescent Hemophilia A and B Patients with Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Apr 2020
OxThera Announces Completion of Recruitment in Phase 3 ePHex Study With Oxabact(R) in Patients With Primary Hyperoxaluria
Biopharmaceuticals
Older Biopharmaceuticals stories   Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.